Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 66710

1.

Egg Intake during Carbohydrate Restriction Alters Peripheral Blood Mononuclear Cell Inflammation and Cholesterol Homeostasis in Metabolic Syndrome.

Andersen CJ, Lee JY, Blesso CN, Carr TP, Fernandez ML.

Nutrients. 2014 Jul 18;6(7):2650-2667.

PMID:
25045936
[PubMed - as supplied by publisher]
Free Article
2.

Do n-3 Polyunsaturated Fatty Acids Increase or Decrease Lipid Peroxidation in Humans?

Kelley NS, Yoshida Y, Erickson KL.

Metab Syndr Relat Disord. 2014 Jul 21. [Epub ahead of print]

PMID:
25045922
[PubMed - as supplied by publisher]
3.

Cardiovascular risk factors of early atherosclerosis in school-aged children after Kawasaki disease.

Cho HJ, Yang SI, Kim KH, Kim JN, Kil HR.

Korean J Pediatr. 2014 May;57(5):217-21. doi: 10.3345/kjp.2014.57.5.217. Epub 2014 May 31.

PMID:
25045363
[PubMed]
Free Article
4.

High-Density Lipoprotein: A Novel Target for Antirestenosis Therapy.

Yin K, Agrawal DK.

Clin Transl Sci. 2014 Jul 15. doi: 10.1111/cts.12186. [Epub ahead of print]

PMID:
25043950
[PubMed - as supplied by publisher]
5.

[Indications for the combination of pravastatin and fenofibrate according to the cardiovascular risk level. Common clinical situations].

Pintó X.

Clin Investig Arterioscler. 2014 Jul;26 Suppl 1:35-9. doi: 10.1016/S0214-9168(14)70025-7. Spanish.

PMID:
25043546
[PubMed - in process]
6.

[Combination of pravastatin and fenofibrate (Pravafenix(®)). Safety studies].

Hernández Mijares A.

Clin Investig Arterioscler. 2014 Jul;26 Suppl 1:25-30. doi: 10.1016/S0214-9168(14)70023-3. Spanish.

PMID:
25043544
[PubMed - in process]
7.

[Efficacy studies].

Pedro-Botet J, Flores-Le Roux JA.

Clin Investig Arterioscler. 2014 Jul;26 Suppl 1:17-9. doi: 10.1016/S0214-9168(14)70021-X. Spanish.

PMID:
25043542
[PubMed - in process]
8.

[The fixed combination of pravastatin and fenofibrate: What can it provide?].

Rodríguez AD.

Clin Investig Arterioscler. 2014 Jul;26 Suppl 1:12-6. doi: 10.1016/S0214-9168(14)70020-8. Spanish.

PMID:
25043541
[PubMed - in process]
9.

[Therapeutic targets in the treatment of dyslipidemia: HDL and non-HDL cholesterol].

Brea Hernando AJ.

Clin Investig Arterioscler. 2014 Jul;26 Suppl 1:3-6. doi: 10.1016/S0214-9168(14)70018-X. Spanish.

PMID:
25043539
[PubMed - in process]
10.

Graphical assessment of incremental value of novel markers in prediction models: From statistical to decision analytical perspectives.

Steyerberg EW, Vedder MM, Leening MJ, Postmus D, D'Agostino RB Sr, Van Calster B, Pencina MJ.

Biom J. 2014 Jul 18. doi: 10.1002/bimj.201300260. [Epub ahead of print]

PMID:
25042996
[PubMed - as supplied by publisher]
11.

Effect of dietary Schizochytrium microalga oil and fish oil on plasma cholesterol level in rats.

Komprda T, Skultéty O, Křížková S, Zorníková G, Rozíková V, Krobot R.

J Anim Physiol Anim Nutr (Berl). 2014 Jul 5. doi: 10.1111/jpn.12221. [Epub ahead of print]

PMID:
25040911
[PubMed - as supplied by publisher]
12.

The prevalence of metabolically healthy obesity: a systematic review and critical evaluation of the definitions used.

Rey-López JP, de Rezende LF, Pastor-Valero M, Tess BH.

Obes Rev. 2014 Jul 16. doi: 10.1111/obr.12198. [Epub ahead of print]

PMID:
25040597
[PubMed - as supplied by publisher]
13.

Low serum level of 1,25(OH)2 D is associated with chronic periodontitis.

Antonoglou GN, Knuuttila M, Niemelä O, Raunio T, Karttunen R, Vainio O, Hedberg P, Ylöstalo P, Tervonen T.

J Periodontal Res. 2014 Jul 7. doi: 10.1111/jre.12207. [Epub ahead of print]

PMID:
25039942
[PubMed - as supplied by publisher]
14.

Acquired lcat deficiency as a major factor in lowering plasma hdl levels in chronic kidney disease.

Calabresi L, Simonelli S, Conca P, Busnach G, Cabibbe M, Gesualdo L, Gigante M, Penco S, Veglia F, Franceschini G.

J Intern Med. 2014 Jul 16. doi: 10.1111/joim.12290. [Epub ahead of print]

PMID:
25039266
[PubMed - as supplied by publisher]
15.

Lipoprotein Particle Concentrations in Children and Adults following Kawasaki Disease.

Lin J, Jain S, Sun X, Liu V, Sato YZ, Jimenez-Fernandez S, Newfield RS, Pourfarzib R, Tremoulet AH, Gordon JB, Daniels LB, Burns JC.

J Pediatr. 2014 Jul 16. pii: S0022-3476(14)00534-4. doi: 10.1016/j.jpeds.2014.06.017. [Epub ahead of print]

PMID:
25039043
[PubMed - as supplied by publisher]
16.

Prevalence of Peripheral Arterial Disease in Subjects at Moderate Cardiovascular Risk: Greek Results of the PANDORA Study.

Carvounis CP, Nikas N.

Hellenic J Cardiol. 2014 Jul-Aug;55(4):294-304.

PMID:
25039025
[PubMed - in process]
Free Article
17.

Systemic inflammation, intestine, and paraoxonase-1.

Vakili L, Navab KD, Shabihkhani M, Pourtabatabaei N, Vazirian S, Barseghian Z, Seyedali S, Hough G.

Adv Exp Med Biol. 2014;824:83-8. doi: 10.1007/978-3-319-07320-0_8.

PMID:
25038995
[PubMed - in process]
18.

Long-term effects of an intensive intervention in HIV-infected patients with moderate-high atherosclerotic cardiovascular risk.

Masiá M, Bernal E, Robledano C, Padilla S, López N, Martínez E, Gutiérrez F.

J Antimicrob Chemother. 2014 Jul 18. pii: dku269. [Epub ahead of print]

PMID:
25038306
[PubMed - as supplied by publisher]
19.
20.

Long-term therapeutic silencing of miR-33 increases circulating triglyceride levels and hepatic lipid accumulation in mice.

Goedeke L, Salerno A, Ramírez CM, Guo L, Allen RM, Yin X, Langley SR, Esau C, Wanschel A, Fisher EA, Suárez Y, Baldán A, Mayr M, Fernández-Hernando C.

EMBO Mol Med. 2014 Jul 18. pii: e201404046. doi: 10.15252/emmm.201404046. [Epub ahead of print]

PMID:
25038053
[PubMed - as supplied by publisher]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk